All Stories

  1. Off-the-shelf GMP-grade UC-MSCs as therapeutic drugs for the amelioration of CCl4-induced acute-on-chronic liver failure in NOD-SCID mice
  2. The RGD-modified self-assembling D-form peptide hydrogel enhances the therapeutic effects of mesenchymal stem cells (MSC) for hindlimb ischemia by promoting angiogenesis
  3. Advances and Perspectives of Pharmaceutical Nanotechnology in mRNA therapy
  4. Therapeutic application of tumour cell‐derived extracellular vesicles for drug‐resistant cancer therapy via interleukin 6/signal transducer and activator of transcription 3 signalling pathway
  5. Intravenously transplanted mesenchymal stromal cells: a new endocrine reservoir for cardioprotection
  6. Nitric oxide improves regeneration and prevents calcification in bio-hybrid vascular grafts via regulation of vascular stem/progenitor cells
  7. A supramolecular hydrogel based on the combination of YIGSR and RGD enhances mesenchymal stem cells paracrine function via integrin α2β1 and PI3K/AKT signaling pathway for acute kidney injury therapy
  8. Dppa3 facilitates self-renewal of embryonic stem cells by stabilization of pluripotent factors
  9. Anti-inflammatory Effects of Mesenchymal Stem Cells and their Secretomes in Pneumonia
  10. Comparison of the treatment efficacy of umbilical mesenchymal stem cell transplantation via renal subcapsular and parenchymal routes in AKI-CKD mice
  11. The sustained PGE2 release matrix improves neovascularization and skeletal muscle regeneration in a hindlimb ischemia model
  12. Editorial
  13. Renal subcapsular delivery of PGE2 promotes kidney repair by activating endogenous Sox9+ stem cells
  14. Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Radiation-Induced Lung Injury via miRNA-214-3p
  15. Embryonic stem cell-derived extracellular vesicles promote the recovery of kidney injury
  16. Meet the Editor-in-Chief
  17. Intravital microscopy imaging of kidney injury and regeneration
  18. CD73+ Mesenchymal Stem Cells Ameliorate Myocardial Infarction by Promoting Angiogenesis
  19. Chitosan hydrogel-loaded MSC-derived extracellular vesicles promote skin rejuvenation by ameliorating the senescence of dermal fibroblasts
  20. Isolation and Multiple Differentiation of Rat Pericardial Fluid Cells
  21. Intranasal delivery of MSC-derived exosomes attenuates allergic asthma via expanding IL-10 producing lung interstitial macrophages in mice
  22. The delivery of hsa-miR-11401 by extracellular vesicles can relieve doxorubicin-induced mesenchymal stem cell apoptosis
  23. Applications of Decellularized Extracellular Matrix for Regenerative Medicine
  24. Arf6-mediated macropinocytosis-enhanced suicide gene therapy of C16TAB-condensed Tat/pDNA nanoparticles in ovarian cancer
  25. Extracellular vesicles derived from human placental mesenchymal stem cells alleviate experimental colitis in�mice by inhibiting inflammation and oxidative stress
  26. <p>Delivery of MSCs with a Hybrid β-Sheet Peptide Hydrogel Consisting IGF-1C Domain and D-Form Peptide for Acute Kidney Injury Therapy</p>
  27. Correction to: IGF-1C domain–modified hydrogel enhanced the efficacy of stem cells in the treatment of AMI
  28. Enhanced therapeutic effects of MSC-derived extracellular vesicles with an injectable collagen matrix for experimental acute kidney injury treatment
  29. In Vivo Tracking of Mesenchymal Stem Cell-Derived Extracellular Vesicles Improving Mitochondrial Function in Renal Ischemia–Reperfusion Injury
  30. IGF-1C domain–modified hydrogel enhanced the efficacy of stem cells in the treatment of AMI
  31. IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE2-mediated M2 macrophage polarization
  32. Mesenchymal Stem Cell-Derived Extracellular Vesicles for Corneal Wound Repair
  33. The Application of Methylprednisolone Nanoscale Zirconium-Porphyrin Metal-Organic Framework (MPS-NPMOF) in the Treatment of Photoreceptor Degeneration
  34. Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease
  35. Nitric‐Oxide‐Releasing Biomaterial Regulation of the Stem Cell Microenvironment in Regenerative Medicine
  36. Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis
  37. The role of biomaterials in stem cell-based regenerative medicine
  38. JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia
  39. MSC-derived sEVs enhance patency and inhibit calcification of synthetic vascular grafts by immunomodulation in a rat model of hyperlipidemia
  40. IGF-1C domain-modified hydrogel enhances therapeutic potential of mesenchymal stem cells for hindlimb ischemia
  41. In Vivo Real-Time Imaging of Extracellular Vesicles in Liver Regeneration via Aggregation-Induced Emission Luminogens
  42. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model
  43. Molecular Imaging of Therapeutic Effect of Mesenchymal Stem Cell-Derived Exosomes for Hindlimb Ischemia Treatment
  44. Embryonic stem cell-derived extracellular vesicles enhance the therapeutic effect of mesenchymal stem cells
  45. Introduction of Perinatal Tissue-Derived Stem Cells
  46. Perinatal Stem Cells in Kidney Regeneration: Current Knowledge and Perspectives
  47. Proangiogenic Features of Perinatal Tissue-Derived Stem Cells in Cardiovascular Disease Therapy
  48. Perinatal Stem Cells
  49. Folic acid-nanoscale gadolinium-porphyrin metal-organic frameworks: fluorescence and magnetic resonance dual-modality imaging and photodynamic therapy in hepatocellular carcinoma
  50. Dppa3 is critical for Lin28a-regulated ES cells naïve–primed state conversion
  51. Dppa3 in pluripotency maintenance of ES cells and early embryogenesis
  52. MSCs inhibit tumor progression and enhance radiosensitivity of breast cancer cells by down-regulating Stat3 signaling pathway
  53. Stat3 activation is critical for pluripotency maintenance
  54. Enhanced Therapeutic Effects of Mesenchymal Stem Cell-Derived Exosomes with an Injectable Hydrogel for Hindlimb Ischemia Treatment
  55. Directed Differentiation of Human Corneal Endothelial Cells From Human Embryonic Stem Cells by Using Cell-Conditioned Culture Media
  56. Intravenous injection of allogeneic umbilical cord-derived multipotent mesenchymal stromal cells reduces the infarct area and ameliorates cardiac function in a porcine model of acute myocardial infarction
  57. Current View on Hematopoiesis and Beyond
  58. Comparison of Teratoma Formation between Embryonic Stem Cells and Parthenogenetic Embryonic Stem Cells by Molecular Imaging
  59. VE-Cadherin regulates the self-renewal of mouse embryonic stem cells via LIF/Stat3 signaling pathway
  60. Knockout of zebrafish interleukin 7 receptor (IL7R) by the CRISPR/Cas9 system delays retinal neurodevelopment
  61. Exosomes from mesenchymal stromal cells enhance imatinib-induced apoptosis in human leukemia cells via activation of caspase signaling pathway
  62. Inflammatory Human Umbilical Cord-Derived Mesenchymal Stem Cells Promote Stem Cell-Like Characteristics of Cancer Cells in an IL-1β-Dependent Manner
  63. Hydrogel-Based Strategies for Stem Cell Therapy
  64. Prostaglandin E2 hydrogel improves cutaneous wound healing via M2 macrophages polarization
  65. Nitric oxide releasing hydrogel promotes endothelial differentiation of mouse embryonic stem cells
  66. A macroporous heparin-releasing silk fibroin scaffold improves islet transplantation outcome by promoting islet revascularisation and survival
  67. Molecular Imaging of Tumor Angiogenesis and Therapeutic Effects with Dual Bioluminescence
  68. Enhanced proangiogenic potential of mesenchymal stem cell-derived exosomes stimulated by a nitric oxide releasing polymer
  69. Down-regulation of interleukin 7 receptor (IL-7R) contributes to central nervous system demyelination
  70. Stat3 phosphorylation is required for embryonic stem cells ground state maintenance in 2i culture media
  71. Three structurally related Copper complexes with two isomers: DNA/BSA binding ability, DNA cleavage activity and excellent cytotoxicity
  72. Transplantation of Human Placenta-Derived Mesenchymal Stem Cells Alleviates Critical Limb Ischemia in Diabetic Nude Rats
  73. Molecular Imaging of Inducible VEGF Expression and Tumor Progression in a Breast Cancer Model
  74. LMO2 promotes tumor cell invasion and metastasis in basal-type breast cancer by altering actin cytoskeleton remodeling
  75. Meet Our Editorial Board Member
  76. Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta
  77. Increased complements and high-sensitivity C-reactive protein predict heart failure in acute myocardial infarction
  78. LMO2 attenuates tumor growth by targeting the Wnt signaling pathway in breast and colorectal cancer
  79. Interferon-γ alters the microRNA profile of umbilical cord-derived mesenchymal stem cells
  80. Erratum: Bone Marrow Mesenchymal Stem Cells (BM-MSCs) Improve Heart Function in Swine Myocardial Infarction Model through Paracrine Effects
  81. Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast cancer
  82. Bone Marrow Is a Reservoir for Cardiac Resident Stem Cells
  83. Bone Marrow Mesenchymal Stem Cells (BM-MSCs) Improve Heart Function in Swine Myocardial Infarction Model through Paracrine Effects
  84. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis
  85. VCAM-1+ placenta chorionic villi-derived mesenchymal stem cells display potent pro-angiogenic activity
  86. Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects
  87. IGF-1 C Domain–Modified Hydrogel Enhances Cell Therapy for AKI
  88. Identification of Stem-Like Cells in Atrial Myxoma by Markers CD44, CD19, and CD45
  89. Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications
  90. Controlled nitric oxide release for tissue repair and regeneration
  91. Translational applications of molecular imaging in cardiovascular disease and stem cell therapy
  92. Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction
  93. Extracellular Matrix can Recover the Downregulation of Adhesion Molecules after Cell Detachment and Enhance Endothelial Cell Engraftment
  94. Gene and MicroRNA Profiling of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells
  95. Activating Transcription Factor 4 Promotes Angiogenesis of Breast Cancer through Enhanced Macrophage Recruitment
  96. Angiogenesis
  97. Molecular Imaging: The Key to Advancing Stem Cell Therapy
  98. OSM Enhances Angiogenesis and Improves Cardiac Function after Myocardial Infarction
  99. Differential effects of tumor necrosis factor-α on matrix metalloproteinase-2 expression in human myometrial and uterine leiomyoma smooth muscle cells
  100. Differential expression of caveolin-1 in human myometrial and uterine leiomyoma smooth muscle
  101. Phase dependent luminescent property of N,N-di(n-octyl)quinacridone crystals
  102. IFN-γ mediates graft-versus-breast cancer effects via enhancing cytotoxic T lymphocyte activity
  103. Molecular imaging for assessment of mesenchymal stem cells mediated breast cancer therapy
  104. Synthesis, Biodistribution, and Imaging of PEGylated-Acetylated Polyamidoamine Dendrimers
  105. Tumor necrosis factor-α regulates matrix metalloproteinase-2 expression and cell migration via ERK pathway in rat glomerular mesangial cells
  106. Bone Marrow Vascular Niche: Home for Hematopoietic Stem Cells
  107. Nanoparticle-Based Tumor Theranostics with Molecular Imaging
  108. The role of Hath6, a newly identified shear-stress-responsive transcription factor, in endothelial cell differentiation and function
  109. Human Embryonic Stem Cell-Derived Endothelial Cells as Cellular Delivery Vehicles for Treatment of Metastatic Breast Cancer
  110. Noninvasive Imaging of Hypoxia-Inducible Factor-1α Gene Therapy for Myocardial Ischemia
  111. Yes-associated protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53
  112. Human embryonic stem cells-derived endothelial cell therapy facilitates kidney regeneration by stimulating renal resident stem cell proliferation in acute kidney injury
  113. Imaging Neural Stem Cell Graft-Induced Structural Repair in Stroke
  114. The Phenotypic Fate of Bone Marrow-Derived Stem Cells in Acute Kidney Injury
  115. Bioluminescence Imaging of Human Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Myocardial Infarction
  116. Transplantation of parthenogenetic embryonic stem cells ameliorates cardiac dysfunction and remodelling after myocardial infarction
  117. Assessment of Therapeutic Efficacy of Liposomal Nanoparticles Mediated Gene Delivery by Molecular Imaging for Cancer Therapy
  118. Bone marrow-derived cells can acquire renal stem cells properties and ameliorate ischemia-reperfusion induced acute renal injury
  119. Improved mesenchymal stem cell survival in ischemic heart through electroacupuncture
  120. CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma
  121. Legumain: A biomarker for diagnosis and prognosis of human ovarian cancer
  122. Fra-1 Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy
  123. Activating transcription factor 4 increases chemotherapeutics resistance of human hepatocellular carcinoma
  124. Functional Characterization and Expression Profiling of Human Induced Pluripotent Stem Cell- and Embryonic Stem Cell-Derived Endothelial Cells
  125. Novel MicroRNA Prosurvival Cocktail for Improving Engraftment and Function of Cardiac Progenitor Cell Transplantation
  126. Preparation and Evaluation of Magnetic Nanoparticles for Cell Labeling
  127. Bioluminescence reporter gene imaging characterize human embryonic stem cell-derived teratoma formation
  128. Effects of Long-Term Culture on Human Embryonic Stem Cell Aging
  129. MicroRNA-210 as a Novel Therapy for Treatment of Ischemic Heart Disease
  130. Effects of Ionizing Radiation on Self-Renewal and Pluripotency of Human Embryonic Stem Cells
  131. Embryonic Stem Cell–Derived Endothelial Cells Engraft Into the Ischemic Hindlimb and Restore Perfusion
  132. Human Neural Stem Cell Grafts Modify Microglial Response and Enhance Axonal Sprouting in Neonatal Hypoxic–Ischemic Brain Injury
  133. A nonviral minicircle vector for deriving human iPS cells
  134. Functional and Transcriptional Characterization of Human Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Myocardial Infarction
  135. nAChRs Mediate Human Embryonic Stem Cell-Derived Endothelial Cells: Proliferation, Apoptosis, and Angiogenesis
  136. Novel Minicircle Vector for Gene Therapy in Murine Myocardial Infarction
  137. Molecular and Magnetic Resonance Imaging of Human Embryonic Stem Cell–Derived Neural Stem Cell Grafts in Ischemic Rat Brain
  138. Imaging Survival and Function of Transplanted Cardiac Resident Stem Cells
  139. Imaging of STAT3 Signaling Pathway During Mouse Embryonic Stem Cell Differentiation
  140. Transplantation of human embryonic stem cell-derived endothelial cells for vascular diseases
  141. Short Hairpin RNA Interference Therapy for Ischemic Heart Disease
  142. Transcriptome Alteration in the Diabetic Heart by Rosiglitazone: Implications for Cardiovascular Mortality
  143. Comparison of Reporter Gene and Iron Particle Labeling for Tracking Fate of Human Embryonic Stem Cells and Differentiated Endothelial Cells in Living Subjects
  144. Genetic Modification of Embryonic Stem Cells with VEGF Enhances Cell Survival and Improves Cardiac Function
  145. Differentiation, Survival, and Function of Embryonic Stem Cell Derived Endothelial Cells for Ischemic Heart Disease
  146. Positron emission tomography imaging of conditional gene activation in the heart
  147. Molecular Imaging of Embryonic Stem Cell Misbehavior and Suicide Gene Ablation
  148. Quantum dot imaging for embryonic stem cells
  149. Anti-angiogenesis effects of meisoindigo on chronic myelogenous leukemia in vitro
  150. Kinetic expression of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) during embryonic stem cell differentiation
  151. Enhancement of neovascularization with cord blood CD133 + cells-derived endothelial progenitor cells transplantation